Journal article

Metformin and salicylate synergistically activate liver AMPK, inhibit lipogenesis and improve insulin sensitivity

Rebecca J Ford, Morgan D Fullerton, Stephen L Pinkosky, Emily A Day, John W Scott, Jonathan S Oakhill, Adam L Bujak, Brennan K Smith, Justin D Crane, Regje M Bluemer, Katarina Marcinko, Bruce E Kemp, Hertzel C Gerstein, Gregory R Steinberg

Biochemical Journal | PORTLAND PRESS LTD | Published : 2015

University of Melbourne Researchers

Grants

Awarded by Canadian Diabetes Association


Awarded by Canadian Institute for Health Research (CIHR)


Awarded by Canadian Foundation for Innovation


Awarded by Australian Research Council


Awarded by National Health and Medical Research Council


Funding Acknowledgements

This study was supported by the Canadian Diabetes Association [grant number OG-1-09-2698-65 (to G.R.S.)]; the Canadian Institute for Health Research (CIHR) [grant numbers MOP-11480 (to G.R.S.), and BPF-112934 (to M.D.F.)]; the Canadian Foundation for Innovation [grant number 2008M00051 (to G.R.S.)]; the Canadian Liver Foundation Undergraduate Scholarship; the Australian Research Council [grant number DP130104548 (to B.E.K.)]; the National Health and Medical Research Council [grant number APP1085460 (to B.E.K. and G.R.S.) and grant number APP1049197 (to J.S.O. and J.W.S.)]; the Victorian Government's Operational Infrastructure Support Program; and Sanofi.